Stocks · Health care · Services-Misc Health & Allied Services, NEC

agilon health, inc.

AGL Clue Score61
United States Fiscal year ends December CIK 0001831097 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Benjamin Shaker
9 Mar 2026
Chief Markets Officer
Buy
18,448
—
no price
Girish Venkatachaliah
9 Mar 2026
Chief Technology Officer
Buy
18,448
—
no price
Denise Zamore
9 Mar 2026
Chief Legal Officer
Buy
5,535
—
no price
Benjamin Shaker
2 Mar 2026
Chief Markets Officer
Buy
500,000
$0.60
$301.05K
John William Wulf
12 Nov 2025
Director
Buy
81,000
$0.63
$50.94K
Girish Venkatachaliah
14 Mar 2025
Chief Technology Officer
Buy
9,429
—
no price
Benjamin Shaker
14 Mar 2025
Chief Markets Officer
Buy
11,786
—
no price
Steven Sell
14 Mar 2025
CEO & President
Buy
42,426
—
no price
Karen McLoughlin
13 Dec 2024
Director
Buy
25,000
$2.20
$55.09K
Silvana Battaglia
11 Dec 2024
Director
Buy
25,062
$2.01
$50.27K
Diana McKenzie
9 Dec 2024
Director
Buy
7,500
$2.20
$16.49K
John William Wulf
5 Dec 2024
Director
Buy
45,000
$2.18
$98.15K
Diana McKenzie
25 Nov 2024
Director
Buy
12,500
$2.28
$28.47K
Steven Sell
12 Sep 2024
CEO & President
Buy indirect
20,000
$3.36
$67.19K
Timothy Bensley
14 Mar 2024
Chief Financial Officer
Buy
14,945
—
no price
Veeral Desai
14 Mar 2024
Chief Strategy & Dev. Officer
Buy
11,956
—
no price
Benjamin Shaker
14 Mar 2024
Chief Markets Officer
Buy
274,455
—
no price
Girish Venkatachaliah
14 Mar 2024
Chief Technology Officer
Buy
5,434
—
no price
Benjamin Kornitzer
14 Mar 2024
Chief Med. & Quality Officer
Buy
5,434
—
no price
Jeffrey A. Schwaneke
29 Nov 2023
Director
Buy
22,300
$11.22
$250.21K
Steven Sell
21 Nov 2023
CEO & President
Buy indirect
44,690
$11.14
$497.74K
Steven Sell
18 Nov 2022
CEO & President
Buy indirect
2,900
$17.14
$49.70K
Michelle A Gourdine
19 Apr 2021
Director
Buy
5,000
$23.00
$115.00K
Clay Richards
19 Apr 2021
Director
Buy
21,700
$23.00
$499.10K

What was left out

Form 4 filings counted 210
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 128
Sales at will 16
Transactions with no price 12
Shares from compensation/vesting 11,666,485
Sales filed before the plan box existed 15
History held since 16 Apr 2021